Picard Medical CEO to Present Emperor Total Artificial Heart at CSI Focus D-HF in Frankfurt
Picard Medical Inc.'s CEO, Patrick NJ Schnegelsberg, will present data on the Emperor Total Artificial Heart at the CSI Focus D-HF conference in Frankfurt on December 6, 2025. The presentation will take place from 13:00 to 13:45 CET during the “Durable Mechanical Circulatory Support” session.
Picard Medical Inc., parent company of SynCardia Systems LLC, will participate in the CSI Focus D-HF (Device Therapies in Heart Failure) conference in Frankfurt, Germany. CEO Patrick NJ Schnegelsberg is scheduled to present data on the fully implantable Emperor Total Artificial Heart (TAH) on Saturday, December 6, 2025, from 13:00 to 13:45 CET during the “Durable Mechanical Circulatory Support” session in the Red Room. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-25-009661), on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
